Latest Resources

Watch "Treatable Traits for Long COVID"

Watch Professor James Hull present a webinar on "Bedside to Podium"- Physical Activity and the Limiting Factors

Landscape fires are increasing in frequency and severity globally. They cause large health and socioeconomic burden for communities and governments. People with asthma are particularly vulnerable to the effects of landscape fire smoke exposure. View our infographic below for more details

Treatable Traits is a model of care that can be used to address the complexity of Long COVID. Learn more by downloading our infographic

Watch Associate Professor Vanessa Murphy present on "Breathing for Two Managing asthma in pregnancy and breaking the cycle of asthma in the next generation"

Watch Professor Luke Wolfenden present on how to undertake implementation trials

How can Treatable Traits be applied across different healthcare settings? Download our infographic to find out more

Watch Professor Vibeke Backer discussion difficult to manage chronic rhinosinusitis and asthma

What is asthma remission? Read on to find out!

Stress is the reaction to a potentially threatening or demanding situation, which can be acute or chronic. Many people report that stress triggers their asthma and this has been linked to poor asthma prognosis.

Chronic breathlessness is a common symptom in people with chronic respiratory diseases. Chronic breathlessness is complex, while commonly caused by chronic lung conditions, there are many other underlying contributing factors. However, chronic breathlessness often persists despite treatment of underlying conditions. Learn more about chronic breathlessness using our infographic

In a single year one quarter of people with asthma have cumulative exposure to oral corticosteroid levels associated with long term toxicity.

Airflow limitation means that the flow of air through the airways is impaired. The presence, level and severity of airflow limitation can be different for people with asthma and chronic obstructive pulmonary disease.

This document provides a summary of the literature relevant to Treatable Traits published between March 2021- September 2021.

Oral corticosteroids (OCS) are an effective treatment for acute and chronic severe asthma. However the indiscriminate use of OCS poses a risk of serious side effects and irreversible harm. There is an urgent need to introduce OCS stewardship approaches.

This webinar presented Professor Andrew Searles and Dr. Shanti Ramanathan provides guidance on how to conduct research impact assessment using the FAIT model.

Research published by the Centre of Excellence- Treatable Traits investigators are highlighted below. These publications focus on articles that are directly relevant to Treatable Traits in chronic airway diseases.

Not all asthma or COPD are the same. These conditions are complex and heterogeneous in terms of their associated traits and comorbidities. Learn more using our infographic below.

Multidimensional assessment is a systematic assessment of a patient’s symptoms and comorbidities. Learn more using our infographic below.

Asthma is a long-term lung condition that affects one in nine Australians, one of the highest rates in the world. It has a significant impact on people's health, quality of life and the health care system.

April 29th we celebrated the launch of The Centre of Excellence in Treatable Traits. Throughout the presentations Directors, Professor Vanessa McDonald and Conjoint Professor Peter Gibson along with Chief Investigator Professor Ian Pavord, explore the necessity of Treatable Traits and how we plan to implement this novel management of chronic airway disease.

Women with asthma are at increased risk of poor pregnancy outcomes, including preterm birth, low birth weight, caesarean section, gestational diabetes and neonatal hospitalisation, among others. Watch Professor Vanessa McDonald, Professor Michael Peek and Dr Vanessa Murphy discuss how the treatable traits approach can be applied to asthma in pregnancy.

Treatable Traits is a model of care designed to address the heterogeneity of chronic airway diseases, such as COPD and asthma. Learn more using our infographic below.